Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs
- 28 April 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 235 (2-3) , 245-253
- https://doi.org/10.1016/0014-2999(93)90143-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effects of FRG-8813, a new type histamine H2-receptor antagonist, on various experimental gastric and duodenal lesions in rats.Folia Pharmacologica Japonica, 1992
- Effects of FRG-8813, a new-type histamine H2-receptor antagonist, on the healing of gastric and duodenal ulcer in rats and spontaneously ulcerative mice.Folia Pharmacologica Japonica, 1992
- Role of acetylcholine, histamine and gastrin in the acid response to intracisternal injection of TRH analog, RX 77368, in the ratRegulatory Peptides, 1990
- Gastric Mucosal Resistance and Prostanoid Levels after Cimetidine Treatment in RatsDigestion, 1988
- H2-receptor antagonist and gastric acid antisecretory properties of Wy-45,662Inflammation Research, 1986
- Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an unsurmountable histamine H2‐receptor blocking drugBritish Journal of Pharmacology, 1985
- Histamine H2-Antagonists-Past, Present and FutureJournal of Clinical Gastroenterology, 1983
- DIFFERENCE IN RELAPSE RATES OF DUODENAL ULCER AFTER HEALING WITH CIMETIDINE OR TRIPOTASSIUM DICITRATO BISMUTHATEThe Lancet, 1981
- Recurrence of duodenal ulcer pain after treatment with cimetidine for four and eight weeks.Gut, 1980
- CONTINUOUS RECORDING OF ACID GASTRIC SECRETION IN THE RATBritish Journal of Pharmacology and Chemotherapy, 1958